ICD
Get informed when a big investor buys or sells
+ FollowUndervalued by 322.6% based on the discounted cash flow analysis.
| Market cap | $8.92 Million |
|---|---|
| Enterprise Value | $204.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.69 |
| Beta | 4.96 |
| Outstanding Shares | 14,528,000 |
| P/E Ratio | -0.22 |
|---|---|
| PEG | -0.15 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | 1.18 |
| Enterprise Value to EBIT | -5.48 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | 1.44 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data